T13281 |
Valopicitabine
|
640281-90-9
|
98%
|
|
Valopicitabine is an effective prodrug of the effective anti-HCV drug 2'-C-methylcytidine and can be used as a promising antiviral drug for the study of chronic ...
|
TN1703 |
Glycyrin
|
66056-18-6
|
98%
|
|
Glycyrin, one of the main PPAR-gamma ligands of licorice, can significantly decrease the blood glucose levels of genetically diabetic KK-A(y) mice.
|
T16774 |
RO-9187
|
876708-03-1
|
98%
|
|
RO-9187 is an effective HCV virus replication inhibitor(IC50: 171 nM).
|
TQ0030 |
Tomeglovir
|
233254-24-5
|
98%
|
|
Tomeglovir is a potent anti-CMV agent, inhibiting the processing of viral DNA-concatemers (IC50s: 0.34/0.039 μM for HCMV and MCMV).
|
T12966 |
Sofosbuvir impurity K
|
1496552-51-2
|
98%
|
|
Sofosbuvir impurity K is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity.
|
T12033 |
Micrococcin P1
|
67401-56-3
|
98%
|
|
Micrococcin P1 is a macrocyclic peptide antibiotic and is a potent hepatitis C virus (HCV) inhibitor(EC50 range of 0.1-0.5 μM)
|
T12956 |
Sofosbuvir impurity A
|
1496552-16-9
|
98%
|
|
Sofosbuvir impurity A is an diastereoisomer of Sofosbuvir. Sofosbuvir is anHCV RNA replication inhibitor ,with potent anti-hepatitis C virus activity.
|
T5539 |
GS-443902
|
1355149-45-9
|
98%
|
|
GS-441524 was shown to be a safe and effective treatment for feline infectious peritonitis (FIP). The optimum dosage was found to be 4.0 mg/kg SC q24h for at lea...
|
TN5079 |
Sulochrin
|
519-57-3
|
98%
|
|
Sulochrin shows antifungal and antibacterial activities, it can inhibit hepatitis C virus (HCV) infection in a dose-dependent manner without any apparent cytotox...
|
T10067 |
2',5-Difluoro-2'-deoxycytidine
|
581772-30-7
|
98%
|
|
2',5-Difluoro-2'-deoxycytidine has potent anti-HCV activity and toxicity to rRNA.
|
TN5263 |
1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one
|
569-83-5
|
98%
|
|
Xanthohumol, prenylchacone flavonoid, is a natural product with multi-biofunctions purified from Hops Humulus lupulus. Xanthohumol is effective against HIV-1 and...
|
TQ0162 |
R-1479
|
478182-28-4
|
98%
|
|
R-1479 is an HCV replication inhibitor in the HCV subgenomic replicon system (IC50: 1.28 μM).
|
TQ0122 |
VCH-916
|
1200133-34-1
|
98%
|
|
VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.
|
T14555 |
BI-1230
|
849022-32-8
|
98%
|
|
BI-1230 is potent and digit nanomolar inhibitor of HCV NS3 protease and of viral replication and it is also highly selective against other serine/cysteine protea...
|
T12965 |
Sofosbuvir impurity J
|
1334513-10-8
|
98%
|
|
Sofosbuvir impurity J is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity.
|
T12969 |
Sofosbuvir impurity N
|
1394157-34-6
|
98%
|
|
Sofosbuvir impurity N is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity.
|
TN3809 |
Dehydrojuncusol
|
117824-04-1
|
98%
|
|
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is acti...
|
T9567 |
Samatasvir
|
1312547-19-5
|
98%
|
|
Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
|
TQ0090 |
Nesbuvir
|
691852-58-1
|
98%
|
|
Nesbuvir (HCV-796) is a nonnucleoside inhibitor of the HCV nonstructural protein 5B (NS5B) polymerase.
|
T14095 |
ACH-806
|
870142-71-5
|
98%
|
|
ACH-806 is an NS4A antagonist. It can inhibit Hepatitis C Virus (HCV) replication with an EC50 of 14 nM.
|